Jen‐Kou Lin

Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions.

Ann‐Lii Cheng, Chih‐Hung Hsu, Jen‐Kou Lin et al. · PubMed · 2001 · 2.1K citations

Medicine, Oncology, Pharmacology +10

UGT1A1*28 polymorphism predicts irinotecan‐induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma

Chun‐Yu Liu, Po‐Min Chen, Tzeon‐Jye Chiou et al. · Cancer · 2008 · 113 citations

Medicine, Oncology, Pharmacology +16

Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry

Felice Giuliante, Luca Viganò, Agostino Maria De Rose et al. · Annals of Surgical Oncology · 2021 · 111 citations · Full text

Medicine, Oncology, Surgery +17

Diffuse reflectance spectroscopy detects increased hemoglobin concentration and decreased oxygenation during colon carcinogenesis from normal to malignant tumors

Hsing-Wen Wang, Jeng‐Kai Jiang, Chi‐Hung Lin et al. · Optics Express · 2009 · 85 citations · Full text

Natural Sciences, Oncology, Pathobiology +16

<i>BRAF</i> mutation is a prognostic biomarker for colorectal liver metastasectomy

Hao‐Wei Teng, Yu‐Chung Huang, Jen‐Kou Lin et al. · Journal of Surgical Oncology · 2012 · 83 citations

Medicine, Oncology, Pathology +17